Psychedelics Incannex orders psilocybin and MDMA from PharmAla Biotech Incannex plans to open a series of psychedelics clinics in Australia and use PharmAla's products Rowan DunneApril 25, 2023
Cannabis Aurora Cannabis expands Australian portfolio with new high THC product Patients registered under MedReleaf Concession Scheme can then access the new high-THC product Tempo 26 Natalia Buendia CalvilloApril 12, 2023
Medical and Pharmaceutical PharmAla Biotech and Filament Health partner to release MDMA capsules The capsules are GMP certified and will be used in clinical trials and by authorized patients Natalia Buendia CalvilloApril 11, 2023
Psychedelics Optimi Health secures MDMA and psilocybin distribution agreement in Australia The company will supply Mind Medicine Australia with the substances, now considered designated therapies in the country Rowan DunneMarch 1, 2023
Gold Catalyst Metals acquires Superior Gold for $55M forming new mid-tier Australian gold producer Catalyst will also be acquiring Vango Mining, which owns a gold project adjacent to Superior's Plutonic mine Rowan DunneFebruary 27, 2023
Gold Newcrest Mining rejects Newmont’s US$17B takeover bid Newcrest says the unsolicited offer would not represent sufficient value for its shareholders Rowan DunneFebruary 16, 2023
Cannabis Delta 9 Cannabis completes first international pot shipment to Australia The company now also plans to send 100 kg of flower and 6 kg of distillate to the country before the end of June Rowan DunneFebruary 14, 2023
Psychedelics PharmAla Biotech signs agreement to sell clinical-grade MDMA in Australia Companies are running more MDMA and psilocybin trials after the Australian drug regulation changes Natalia Buendia CalvilloFebruary 14, 2023
Gold Karora Resources observes 34% increase in inferred gold at Australian mine Measured and indicated gold resources have also increased by 20% while proven and probable reserves increased by 12% Rowan DunneFebruary 13, 2023
News Australia re-classifies MDMA and psilocybin to be prescribed as medicine Psychiatrists can now prescribe MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression Natalia Buendia CalvilloFebruary 3, 2023